AUG 26·SEC EDGAR 8-KMed
Black Hawk Acquisition Corp (BKHA): Entry into a Material Definitive Agreement
Black Hawk Acquisition Corp (BKHA) filed an SEC Form 8-K — Entry into a Material Definitive Agreement.
StockNASDAQ · US · USDReal Estate · BLANK CHECKS
$BKHAR
Black Hawk Acquisition Corp
Price · $BKHARvia TradingView
AI sentiment · 7d1 articles
- Bullish
- 0
- Neutral
- 1
- Bearish
- 0
Insider · 30dAll trades →
No SEC Form 4 filings for $BKHAR in the last 30 days.
See all $BKHAR insider activity →Top stories · $BKHARMore →
MAY 1·Stock Titan
BKHA SEC Filings - Black Hawk Acquisition Corp 10-K, 10-Q, 8-K Forms
This article provides a comprehensive overview of Black Hawk Acquisition Corp (BKHA) SEC filings, including 10-K, 10-Q, and 8-K forms, available on Stock Titan. It details several key filings, such as the proposed merger with Vesicor Therapeutics, extension payments to the trust account, notifications of late filings, and insider ownership disclosures. The platform also offers AI-powered summaries and sentiment analysis for each document to aid investor understanding.
MAR 5·TradingView
BKHA Stock Price and Chart — NASDAQ:BKHA
This article provides detailed financial information and performance analysis for Black Hawk Acquisition Corporation (BKHA) on NASDAQ. It covers key statistics like market capitalization, P/E ratio, and basic EPS, along with technical indicators and historical price movements. The company is a blank check company founded on September 28, 2023, and the article also addresses frequently asked questions about its stock performance and financials.
BKHAR sentiment & insider activity
Over the past 7 days, alphai's AI scored 1 news story mentioning BKHAR (Black Hawk Acquisition Corp). Coverage has been balanced: 0 bullish, 1 neutral, and 0 bearish.
Recent BKHAR coverage spans financial news and corporate actions.
What's driving BKHAR
Black Hawk Acquisition Corp (BKHA) filed an SEC Form 8-K — Entry into a Material Definitive Agreement.
This article provides a comprehensive overview of Black Hawk Acquisition Corp (BKHA) SEC filings, including 10-K, 10-Q, and 8-K forms, available on Stock Titan. It details several key filings, such as the proposed merger with Vesicor Therapeutics, extension payments to the trust account, notifications of late filings, and insider ownership disclosures. The platform also offers AI-powered summaries and sentiment analysis for each document to aid investor understanding.
This article provides detailed financial information and performance analysis for Black Hawk Acquisition Corporation (BKHA) on NASDAQ. It covers key statistics like market capitalization, P/E ratio, and basic EPS, along with technical indicators and historical price movements. The company is a blank check company founded on September 28, 2023, and the article also addresses frequently asked questions about its stock performance and financials.
Black Hawk Acquisition Corporation (BKHA) has announced a sponsor-backed convertible note financing of up to $300,000 from Black Hawk Management LLC to cover working capital needs. The note bears 10% annual interest and matures upon the initial business combination or liquidation, with the sponsor having the option to receive cash repayment or convert the note into equity at $1.00 per share in a DeSPAC transaction. This flexible financing structure supports the SPAC's deal execution while aligning the sponsor's incentives with the combined company's future performance.
The amendment to the proxy statement indicates ongoing corporate actions that may affect the company's valuation and investor confidence.
alphai scores every news story that mentions BKHAR with an AI model for sentiment and relevance, and aggregates insider trades from Black Hawk Acquisition Corp's SEC EDGAR Form 4 filings. Figures refresh continuously.
News on $BKHAR
Score
Black Hawk Acquisition Corp (BKHA): Entry into a Material Definitive Agreement
Black Hawk Acquisition Corp (BKHA) filed an SEC Form 8-K — Entry into a Material Definitive Agreement.
1 min read
BKHA SEC Filings - Black Hawk Acquisition Corp 10-K, 10-Q, 8-K Forms
This article provides a comprehensive overview of Black Hawk Acquisition Corp (BKHA) SEC filings, including 10-K, 10-Q, and 8-K forms, available on Stock Titan. It details several key filings, such as the proposed merger with Vesicor Therapeutics, extension payments to the trust account, notifications of late filings, and insider ownership disclosures. The platform also offers AI-powered summaries and sentiment analysis for each document to aid investor understanding.
4 min readBKHA Stock Price and Chart — NASDAQ:BKHA
This article provides detailed financial information and performance analysis for Black Hawk Acquisition Corporation (BKHA) on NASDAQ. It covers key statistics like market capitalization, P/E ratio, and basic EPS, along with technical indicators and historical price movements. The company is a blank check company founded on September 28, 2023, and the article also addresses frequently asked questions about its stock performance and financials.
3 min read
Black Hawk Acquisition Announces Sponsor-Backed Convertible Note Financing
Black Hawk Acquisition Corporation (BKHA) has announced a sponsor-backed convertible note financing of up to $300,000 from Black Hawk Management LLC to cover working capital needs. The note bears 10% annual interest and matures upon the initial business combination or liquidation, with the sponsor having the option to receive cash repayment or convert the note into equity at $1.00 per share in a DeSPAC transaction. This flexible financing structure supports the SPAC's deal execution while aligning the sponsor's incentives with the combined company's future performance.
2 min readBlack Hawk Acquisition Corporation Amends Its Definitive Proxy Statement
DANVILLE, Calif., July 07, 2025 ( GLOBE NEWSWIRE ) -- Black Hawk Acquisition Corporation ( NASDAQ: BKHAU, the "Company" ) announced today that it filed a supplement to its definitive proxy statement, originally filed with the Securities and Exchange Commission on June 10, 2025, to amend the ...
3 min read
Black Hawk Acquisition Corporation Amends Its Definitive Proxy Statement - Black Hawk Acquisition (NASDAQ:BKHAU)
DANVILLE, Calif., June 20, 2025 ( GLOBE NEWSWIRE ) -- Black Hawk Acquisition Corporation BKHAU the "Company" ) ) announced today that it filed a supplement to its definitive proxy statement, originally file with the Securities and Exchange Commission on June 10, 2025, to amend the language of ...
2 min readBlack Hawk Acquisition Corporation Amends Its Definitive Proxy Statement
DANVILLE, Calif., June 20, 2025 ( GLOBE NEWSWIRE ) -- Black Hawk Acquisition Corporation ( NASDAQ: BKHAU, the "Company" ) announced today that it filed a supplement to its definitive proxy statement, originally file with the Securities and Exchange Commission on June 10, 2025, to amend the ...
2 min readVesicor Therapeutics, Inc. and Black Hawk Acquisition Corporation Enter into a Business Combination Agreement to Create a Biotechnology Company Advancing p53-based Cancer Therapeutics Delivered Via Microvesicles
DANVILLE, Calif., April 28, 2025 ( GLOBE NEWSWIRE ) -- Black Hawk Acquisition Corp. ( Nasdaq: BKHAU, BKHA, BKHAR ) , a special purpose acquisition company, ( "Black Hawk" ) announced the signing of a Business Combination Agreement ( "BCA" ) on April 26, 2025, with Vesicor Therapeutics, Inc. ( ...
3 min readVesicor Therapeutics, Inc. and Black Hawk Acquisition Corporation Enter into a Business Combination Agreement to Create a Biotechnology Company Advancing p53-based Cancer Therapeutics Delivered Via Microvesicles - Black Hawk Acquisition (NASDAQ:BKHAU)
Transaction Values Vesicor at a Pre-money Equity Value of $70 million Business Combination is Expected to be Completed in the Fourth Quarter of 2025 DANVILLE, Calif., April 28, 2025 ( GLOBE NEWSWIRE ) -- Black Hawk Acquisition Corp.
3 min read